PER percheron therapeutics limited

atl1103 development update, page-69

  1. 2,843 Posts.

    quote from yesterdays announcement regarding ATL1103 phase2.

    "with interim results potentially available in early to mid 2013."

    I hope you understand the term interim because my understanding is that its first stages of the phase 2.
    So that gives a clear window of 18 months for interim and then further with the advanced results of phase2.

    I am not downramping here but i will not accept "takeovers" and pie in the sky figures when this is all dreams and highly speculative thinking at best.

    Deal in facts is the fair thing here but in any case i just have a passing interest and good luck to all.

    Done and Dusted on this one.
    Cheers
    Rob
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.001(12.5%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $6.11K 690K

Buyers (Bids)

No. Vol. Price($)
23 6305225 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1171332 5
View Market Depth
Last trade - 14.32pm 10/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.